Chapter 15: Disorders of Motor Function

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive.

Think about just signing your name, or maybe tying a shoe.

Movement feels effortless, usually.

But it's this incredibly complex symphony, and when that symphony breaks down, well, that's what we're exploring today.

The difference between smooth intended actions and movements that become involuntary, disruptive, or even paralyzing.

So today we're doing a critical deep dive into chapter 15 of Porthos Essentials of Pathophysiology.

We're focusing only on the organization and disorders of motor function, our mission, to give you that essential roadmap for figuring out where and maybe how movement goes wrong.

Absolutely.

And to really get that, you have to start with the basic framework.

All movement really depends on a functional hierarchy.

It starts right down at the motor unit that's the lower motor neuron and the muscle fibers it connects to.

Then you move up through the spinal cord, the brain stem, then through the coordinating centers, the cerebellum, basal ganglia, and finally, everything gets its purpose and direction from the motor cortex up top.

Okay, let's really unpack that.

We need this core framework, this diagnostic lens, right?

Comparing the upper motor neurons, the UMNs, which start in the brain and stay within the central nervous system against the lower motor neurons, the LMNs, which actually leave the spinal cord to talk directly to the muscle.

Exactly.

And damage to one versus the other.

Yeah.

Completely different clinical pictures.

It's fundamental.

The UMN and LMN distinction is, well, it's everything for diagnosis.

Think of the UMNs as providing that supervisory control from the brain.

They modulate, they inhibit the reflexes down in the spinal cord.

Right.

They're like the brakes.

Precisely.

So if you damage the UMNs, if you cut those brake lines, the spinal cord reflexes are just left unchecked.

They start overfiring.

Okay.

So the brain loses control and everything below that lesion level just fires wildly.

Got it.

But let's start at the command center itself.

The motor cortex, highest level stuff.

What's the setup there?

Oh, it's incredibly specialized.

You've basically got three key areas working together.

First,

the primary motor cortex.

Think of that as the direct line to the muscles.

It's all about the execution.

Firing the specific muscle sequences needed for an action.

And this is where that famous motor homunculus lives.

Ah, yes.

The little man map.

Exactly.

That distorted map.

It shows you visually how much brain power is dedicated to controlling the hands, the face,

the mouth for speech.

Huge areas compared to, say, the trunk.

It really drives home where the fine control is needed.

So if the primary is execution, the conductor, then the pre -motor cortex.

Is that like the planning department?

That's a great way to put it.

Yeah.

The pre -motor cortex sits just in front, and it's responsible for planning those complex movement patterns, like figuring out the exact sequence of muscle contractions needed to pick up a delicate glass without dropping or crushing it.

Okay.

And the third one.

The supplementary motor cortex.

This one is key for complex, skillful movements that require coordinating both sides of the body.

Think about

playing the piano or serving a tennis ball.

Needs both hands, both sides working together smoothly.

Makes sense.

So we have the command center.

Now what about the highways down from the brain?

You mentioned two main systems, pyramidal and extra -pyramidal.

What's the core difference?

Okay.

The pyramidal system, sometimes called the direct pathway, is your express route for fine, skilled, delicate movements.

Precision work.

When you have a disorder here, like a major stroke affecting that pathway,

well that often results in paralysis, a complete loss of voluntary movement, and typically severe spasticity.

Okay.

Direct route, fine control, damage means paralysis and spasticity.

What about the other one?

The extra -pyramidal.

Right.

The extra -pyramidal or indirect pathway.

This system originates largely in the basal ganglia.

It's less about fine skill and more about the background support system.

It handles crude movements, postural adjustments, the automatic things like swinging your arms when you walk.

It provides the stable backdrop for the skilled movements.

And if that system breaks down, like in Parkinson's.

Ah, exactly.

With extra -pyramidal disorders like Parkinson's, you see involuntary movements, tremors, rigidity.

But here's the key distinction.

Generally, without paralysis, the person can still move, technically.

Their muscles work.

But they lose the ability to control the timing, the smoothness, and they can't suppress unwanted movements.

The background control is gone.

That's a crucial difference.

And we can test for UMN versus LMN problems pretty easily at the bedside with reflexes, right?

The deep tendon reflexes, DTRs.

Absolutely.

It's a cornerstone of the neuro exam.

If those UMN breaks are damaged, the reflex response is exaggerated.

You tap the tendon and the limb jumps way more than it should.

That's hyperreflexia.

And it points strongly towards an UMN lesion somewhere in the brain or spinal cord.

And the opposite.

If you see hyperreflexia, meaning a weak or even absent reflex, that suggests the problem is in the LMN system.

Either the peripheral nerve itself, the neuromuscular junction, the muscle, or maybe the specific spinal cord segment where that reflex arc lives is damaged.

And you'd also be looking at muscle tone, wouldn't you?

Definitely.

LMN problems usually cause hypotonia or flaccidity.

The muscle feels limp, ploppy.

UMN problems, on the other hand, lead to hypertonia, which can manifest as either spasticity, that velocity dependent resistance, or rigidity, like in Parkinson's, that resistance throughout the range of motion.

Okay, so we've got the central command and the highways mapped out.

Let's zoom all the way down now to the end of the line.

The motor unit itself, the LMN and the muscle fibers it controls.

What happens when that connection fails?

Well, the most obvious thing is muscle atrophy, wasting away.

But there's a difference.

If you just don't use a muscle, say your arms in a cast, you get disuse atrophy.

The muscle fibers shrink, but they're still alive.

But if the lower motor neuron itself dies, if that nerve supply is cut off permanently, then you get denervation atrophy that's much more severe.

The muscle fibers lose their contractile proteins, die off, and eventually get replaced by fibrous tissue and fat.

And this difference helps explain some subtle signs we might see or detect.

Yes.

For example, after denervation, the individual muscle fibers become unstable and can start contracting spontaneously.

These are tiny contractions called fibrillations, and you can only detect them with an EMG needle electrode.

They're not visible.

Okay, fibrillations are microscopic post -denervation.

What about twitches we can see?

Right.

If the lower motor neuron isn't dead but is sick or hyper -excitable, it can start firing randomly, causing groups of muscle fibers and tire motor units to contract together.

That visible twitching under the skin, that's fasciculations.

Seeing those is a really key sign pointing towards LMN disease.

Got it.

Now, thinking about primary muscle diseases, the textbook example has to be Duchenne Muscular Dystrophy, DMD.

It is.

DMD is a devastating X -link genetic disorder, so it primarily affects boys.

And it's caused by a mutation in the gene for a crucial protein called dystrophin.

Dystrophin.

Why is that protein so critical for muscle function?

Think of dystrophin as a key part of the muscle cell's internal scaffolding.

It helps anchor the contractile apparatus, the actin and myosin, to the cell membrane.

It acts like a shock absorber during contraction.

Without functional dystrophin, the muscle cell membrane becomes fragile, easily damaged during contraction.

This leads to a cascade of inflammation,

cell death, and progressive replacement of muscle tissue with fat and fibrous connective tissue.

Which explains that strange sign pseudohypertrophy.

Exactly.

Particularly in the calf muscles early on, the muscle actually looks bigger, hypertrophied, but it's false hypertrophy pseudo.

The bulk isn't functional muscle, it's infiltration by fat and scar tissue.

So despite the size, the muscle is actually getting weaker.

Okay, moving just one step up from the muscle, we hit the connection point, the neuromuscular junction, the NMJ.

And the classic disorder here is Myasthenia Gravis, M .G.

Ah, yes, M .G.

This one's fascinating because it's an autoimmune disease.

The body's own immune system mistakenly produces antibodies that attack and block or destroy the acetylcholine receptors, the ACHRs, on the muscle side of the NMJ.

So the signal from the nerve, the acetylcholine, can't properly activate the muscle.

Precisely.

There are fewer functional receptors available.

This leads to the hallmark symptoms.

Muscle weakness and profound fatigue that characteristically gets worse with repeated effort and often progresses throughout the day.

Someone with M .G.

might wake up feeling relatively okay, but their strength rapidly diminishes as they use their muscles.

And it often starts with specific muscles, right?

Very often, yes.

The small, frequently used muscles of the eyes and eyelids are typically affected first.

So early symptoms are commonly lactosis, the drooping eyelid, and diplopia, or double vision.

Difficulty swallowing or chewing can also occur early.

And clinically, it's important to know about things that can worsen it, like certain drugs.

Absolutely.

The textbook specifically mentions

aminoglycoside antibiotics, drugs like gentamisin.

They should generally be avoided in patients with M .G.

because they can actually interfere with the release of acetylcholine from the nerve terminal, making the weakness even worse.

Good practical point.

Okay.

Lastly, in this motor unit section, let's touch on peripheral nerve disorders themselves, the LMNs.

We distinguish between affecting one nerve versus many.

Right.

A modern neuropathy means damage to a single peripheral nerve.

The classic example is carpal tunnel syndrome, where the median nerve gets compressed as it passes through the carpal tunnel in the wrist.

A polyneuropathy, on the other hand, involves damage to multiple peripheral nerves, usually symmetrically.

Often these start distally in the feet and hands because the longest axons seem to be the most vulnerable to metabolic or toxic damage.

Diabetes is a common cause.

And for carpal tunnel, there are those specific provocative tests.

Yes.

The tidal sign, where tapping over the median nerve at the wrist reproduces tingling into the fingers, and the Phalen maneuver, where fully flexing the wrist for a minute or so, compresses the nerve and brings on the symptoms.

Those are key diagnostic clues.

And then there's a really critical polyneuropathy, Guillain -Barre syndrome, GBS.

GBS is different.

It's an acute immune -mediated polyneuropathy, often triggered by an infection a few weeks trier.

The immune system mistakenly attacks the myelin sheath of peripheral nerves.

The hallmark feature is rapidly progressive,

ascending muscle weakness.

It typically starts in the legs and moves upwards, symmetrically.

It causes flaccid paralysis.

And the major danger there is respiratory failure, isn't it?

That's the critical concern.

If the paralysis ascends high enough to involve the diaphragm and intercostal muscles, the patient can't breathe adequately and will require mechanical ventilation.

So close monitoring of respiratory function is absolutely vital in GBS.

Okay.

Let's shift our focus back up into the brain, but this time looking at the structures that coordinate and refine movement rather than directly commanding it.

First, the cerebellum.

Right.

The cerebellum, located at the back of the brain, is absolutely vital for smooth, coordinated, accurately timed movements.

Think about things like running, typing, playing a musical instrument,

actions that require rapid adjustments and precise control.

Importantly, damage to the cerebellum typically causes problems with coordination, but it doesn't cause paralysis.

The strength is often still there, but the control is lost.

So what does that loss of control look like clinically?

The general term for cerebellar incoordination is ataxia.

Cerebellar ataxia often manifests as a

staggering unsteady gait.

Patients might look almost like they're drunk.

We also see dysmetria.

Dysmetria means measure.

So dysmetria is difficulty measuring distance or range for movements.

They might overshoot or undershoot when reaching for an object.

Like trying to touch your nose and missing.

Exactly.

That finger to nose test is classic for dysmetria.

And another key sign is an intention tremor.

This is a tremor that is absent at rest, but appears and often worsens as the person initiates and carries out a voluntary purposeful movement towards a target.

Reaching for that cup makes the handshake.

Okay.

Cerebellum is for smooth coordination, timing,

accuracy.

Damage leads to ataxia, dysmetria, intention tremor.

Now, what about the other major coordination center, the basal ganglia?

The basal ganglia are a group of deep brain structures.

Their role is a bit different.

They're heavily involved in planning and programming movement,

particularly in selecting and initiating wanted movements while suppressing unwanted ones.

They're crucial for automatic learned motor sequences like walking or riding a bike.

So they're like the gatekeeper for movement initiation and suppression.

That's a very good way to think about it.

They help regulate the intensity and scale of movements and crucially inhibit competing or unnecessary motor patterns.

So when the basal ganglia aren't working properly, you tend to see two main types of problems.

Either poverty of movement, difficulty initiating like in Parkinson's or the appearance of excessive involuntary movements because that inhibitory function is lost.

What kind of involuntary movements are we talking about?

Well, tremors common, particularly the resting tremor seen in Parkinson's.

You can also see dystonia, which involves sustained abnormal postures resulting from simultaneous contraction of agonist and antagonist muscles.

And Korea, which are these irregular, unpredictable,

brief, writhing or dance -like movements.

Huntington's disease is the classic example of Korea.

And the absolute archetype of basal ganglia failure is Parkinson's disease, PD.

Let's focus there.

What's actually going wrong in the brain circuits in PD?

Parkinson's involves the progressive degeneration, the death of specific dopamine -producing neurons.

These neurons originate in a part of the midbrain called the substantia negra, and they project up to the striatum, a key part of the basal ganglia.

This pathway is called the negrostriatal pathway.

As these dopamine neurons die off, there's a significant reduction of dopamine in the striatum.

Dopamine normally acts as a key modulator, sort of facilitating smooth, wanted movement and inhibiting unwanted signals.

Losing it disrupts the delicate balance of neurotransmitters within the basal ganglia circuits.

And isn't there a specific microscopic finding associated with this?

Yes.

The pathological hallmark in the remaining neurons in the substantia nigra are abnormal protein clones called Lewy bodies.

Finding those confirms the diagnosis post -mortem.

Okay, so loss of dopamine neurons, Lewy bodies.

What does this look like for the patient?

What's the classic clinical picture of Parkinson's?

It's often described by a quartet of cardinal features.

First, the resting tremor.

This is often the initial symptom.

It's typically a pill -rolling type tremor, most obvious when the limb is at rest and supported.

Crucially, it often decreases or disappears with voluntary movement and is absent during sleep.

Okay, tremor at rest.

What's next?

Second is rigidity.

This is increased muscle tone, a sort of stiffness felt when passively moving the patient's limb.

It's often described as cogwheel rigidity if there's a tremor superimposed, giving it a jerky ratchet -like feel.

Or lead pipe rigidity if it's smooth but stiff resistance.

Got it.

Tremor rigidity.

Third, and perhaps the most disabling feature, is breadykinesia.

This means slowness of movement.

Patients have difficulty initiating movement—ekinesia—and then slowness in executing it.

This leads to things like a shuffling gait with reduced arm swing,

difficulty with fine motor tasks like buttoning clothes, and often a mask -like facial expression due to reduced facial muscle movement.

Then the fourth part of the quartet.

Postural instability.

This tends to develop later in the disease.

Patients lose the normal postural reflexes that help maintain balance, making them unstable and praying to falls, particularly backward falls.

Retropulsion.

Tremor rigidity, breadykinesia, postural instability.

T -R -A -P.

How do we treat it?

The mainstay of treatment for many years has been replacing the lost dopamine.

Since dopamine itself doesn't cross the blood -brain barrier well, we use its precursor, levodopa.

This can cross into the brain, where it's converted into dopamine.

It's usually given with carbidopa, which prevents the levodopa from being broken down the periphery, allowing more to reach the brain and reducing side effects like nausea.

But levodopa isn't a perfect solution long term, is it?

No, unfortunately.

While it can be very effective, especially early on, long -term use often leads to complications.

The most significant is the development of motor fluctuations, particularly the on -off phenomenon.

Patients experience unpredictable shifts between periods of relatively good mobility, on time, when the drug is working, and periods of severe Parkinsonian symptoms and immobility, off time.

Dyskinesias, those involuntary writhing movements, can also occur during peak on times.

And for those struggling with these fluctuations, surgery might be an option.

Yes, deep brain stimulation, DBS, has become an important treatment for advanced PD with motor fluctuations or disabling tremor.

Electrodes are surgically implanted into specific targets within the basal ganglia, like the subthalamic nucleus or globus pallidus.

These electrodes deliver continuous electrical stimulation, which helps to modulate the abnormal brain circuits.

It doesn't cure the disease, but DBS can significantly reduce off time, improve on time quality, lessen dyskinesias, and control tremor, improving overall function for many patients.

It's adjustable and reversible, which is a major advantage.

Okay, now let's move fully into the central nervous system, the CNS, focusing on disorders primarily affecting those upper motor neurons.

We have to start with amyotrophic lateral sclerosis, ALS, also known as Lou Gehrig's disease.

Yes, ALS is a truly devastating neurodegenerative disease.

What makes it unique and frankly terrifying is that it selectively targets motor neurons, both upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord.

But, and this is critical, it typically spares other neurological systems,

meaning the entire sensory system, intellect, cognitive function, and even eye movements usually remain completely intact, often until the very late stages.

The person is fully aware, trapped inside a body that is progressively losing its ability to move.

That's incredibly difficult, and because it affects both UMNs and LMNs, the symptoms are mixed.

Exactly.

You see a combination of UMN signs like spasticity, stiffness, hyperreflexia, and impaired fine motor control, alongside LMN signs like muscle weakness, atrophy, the amyotrophy part of the name, cramps, and those visible twitches, fasciculations.

The disease progression varies, but it's relentlessly progressive.

Eventually, the muscles involved in breathing fail, and death typically results from respiratory failure, usually within three to five years of diagnosis, though some live much longer.

A truly challenging diagnosis.

Okay, next, CNS disorder, multiple sclerosis, MS.

What's the core pathology here?

MS is fundamentally an immune -mediated inflammatory demyelinating disease of the CNS.

Key points there.

Immune system attacks the myelin sheath, the insulation around nerve axons, only within the brain and spinal cord.

The peripheral nervous system is spared.

This inflammation and destruction of myelin leads to the formation of scar tissue or sclerotic lesions called plaques.

These plaques disrupt or block nerve signal conduction along the affected axons.

And where do these plaques tend to form?

They have a predilection for certain areas of the CNS white matter, particularly the optic nerves, the brain stem, the cerebellum, and the spinal cord.

But they can occur anywhere in the CNS white matter.

Which explains why the symptoms are so varied.

Precisely.

The symptoms of MS depend entirely on the location and extent of the demyelination plaques.

Common symptoms include visual disturbances like optic neuritis, inflammation of the optic nerve causing pain and vision loss,

sensory symptoms like numbness, tingling, or pins and needles, paresthesias, muscle weakness, spasticity, balance problems, ataxia, bladder dysfunction, and often profound fatigue that's out of proportion to activity level.

And the disease course isn't always steadily downhill, is it?

No.

The most common clinical course, especially early on, is relapsing remitting MS,

or RMS.

Patients experience episodes of new or worsening symptoms called relapses or exacerbations, which develop over days to weeks, followed by periods of partial or complete recovery called remissions.

Over time, many with RMS may transition to a secondary progressive course with

Okay, MS is demyelination in the CNS, leading to varied, often relapsing symptoms.

Finally, let's cover spinal cord injury, SCI.

SCI involves damage to the neural elements within the spinal canal.

We usually distinguish between the primary injury and the secondary injury.

The primary injury is the initial mechanical damage that occurs at the moment of trauma, compression, contusion, shearing forces.

This damage is often considered irreversible.

But then things get worse.

Yes, unfortunately.

The primary injury triggers a complex cascade of events over the subsequent hours to days and weeks, known as the secondary injury.

This involves things like ischemia, lack of blood flow, edema, swelling, inflammation, glutamate -excited toxicity, free radical damage, and ultimately apoptosis or programmed cell death.

This secondary cascade often causes significantly more damage and functional loss than the initial trauma itself.

And immediately after the injury, there's that period of spinal shock.

This occurs immediately after a severe SCI.

It's a temporary state characterized by a complete loss of all neurological activity motor, sensory, reflex, and autonomic function below the level of the injury.

The muscles are completely flaccid and reflexes are absent.

This can last for hours, days, or even weeks.

As spinal shock resolves, reflexes below the injury level gradually return and often become hyperactive due to the UMN damage.

And we classify the injuries based on the level.

Right.

The level of injury determines the extent of functional loss.

An injury in the cervical region typically results in tetraplegia, also called quadriplegia, affecting all four limbs.

An injury in the thoracic, lumbar, or sacral spine results in paraplegia, affecting the trunk and lower extremities but sparing the arms.

And sometimes the cord isn't completely severed, leading to specific patterns.

Exactly.

There are several incomplete cord syndromes.

A classic one is brown sacral syndrome, which results from hemisection or damage to one side of the spinal cord.

Because different tracks cross at different levels, this causes a very specific pattern.

Loss of motor function and proprioception, position sense, on the same side, ipsilateral, as the injury, below the lesion level.

But loss of pain and temperature sensation occurs on the opposite side, contralateral, below the lesion.

Fascinating pattern.

Now this brings up a critical issue, especially with higher level injuries.

What happens with autonomic control, specifically that dangerous reflex?

You're talking about autonomic dysreflexia.

This is a potentially life -threatening complication seen in patients with SCI at or above the T6 level.

It's essentially a massive, uncontrolled sympathetic nervous system discharge below the level of the injury.

What triggers it?

It's usually triggered by some kind of noxious stimulus below the level of the lesion, most commonly a distended bladder or impacted bowel.

Because the sensory signals from below the injury can't reach the brain properly to modulate the response, they trigger a massive sympathetic outflow.

This causes intense vasoconstriction below the level of injury, leading to a sudden, severe rise in blood pressure.

Dangerous hypertension.

But the body tries to compensate.

Yes.

Barrel receptors in the neck and chest detect this high blood pressure and send signals up to the brainstem via intact cranial nerves.

Glossophrenia and vagus.

The brain tries to lower the pressure by slowing the heart rate, bradycardia, and causing vasodilation.

But because the descending inhibitory signals can't get past the spinal cord lesion, the vasodilation and sweating only occur above the level of injury.

So the patient develops flushing, sweating, and a pounding headache above the lesion, while remaining pale and cool below, with dangerously high blood pressure and slow heart rate.

It's a medical emergency.

A critical thing to recognize.

But even with severe injury, sometimes small differences in the level preserved make a big functional difference.

Absolutely.

Functionally, preserving even one spinal cord level can be transformative.

For instance, an injury at C5 usually spares the deltoid and biceps muscles, allowing shoulder movement and elbow flexion.

But if you preserve C6 function, that adds wrist extension.

And wrist extension is incredibly important because it allows for tenodesis grip.

It's a passive effect.

When someone with C6 function extends their wrist, the tendons naturally cause their fingers to flex into a grasped position.

Even without active finger muscles, they can use this passive tenodesis grasp to hold on to objects, like a cup or a fork.

It dramatically increases independence compared to a C5 level.

So every level matters.

Hashtag to hashtag outro.

So when you pull it all together, what's the big picture here?

I think the core takeaway from this chapter is that understanding movement disorders is all about localization.

It's a system with multiple potential failure points.

You have to figure out where the system failed.

Is it the muscle itself or the NMJ, like an MG?

Is it the peripheral nerve, the LMN, causing flaccidity, atrophy, vesiculations?

Is it the UMM pathways descending from the brain causing spasticity, hyperreflexia?

Or is it the coordination centers, the basal ganglia leading to tremor, rigidity, bradykinesia?

Or the cerebellum leading to ataxia, intention tremor?

The type of clinical sign flaccid versus spastic, resting tremor versus intention tremor really points to the underlying location of the panology.

Understanding how movement is supposed to work is the key to figuring out how it breaks down.

That's a great synthesis.

Okay, let's end with a final provocative thought for you, our listeners, to mull over.

We talked quite a bit about that devastating secondary injury cascade after an acute spinal cord injury.

The ischemia, the inflammation, the cell death that beyond the initial trauma.

Given that the primary injury is often irreversible at the moment it happens, what do you think is the single most critical breakthrough researchers are chasing right now to target that secondary damage?

Is it a specific drug to block an enzyme, a way to reduce inflammation, maybe some kind of neuroprotective agent, or even a scaffolding technique to guide regrowth that could make the biggest difference in maximizing function in those crucial hours and days after the initial hit?

Something to think about.

Thank you for diving deep into PORS Chapter 15 with us today.

We hope this roadmap helps you navigate the complexities of motor function.

Keep digging for knowledge and from the Last Minute Lecture team, we'll see you for the next deep dive.